Published in Cell Death Differ on March 28, 2014
Lineage factors and differentiation states in lung cancer progression. Oncogene (2015) 0.81
Targeting cancer stem cells by using the nanoparticles. Int J Nanomedicine (2015) 0.79
KRAS-dependent suppression of MYC enhances the sensitivity of cancer cells to cytotoxic agents. Oncotarget (2017) 0.75
Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02
Comprehensive genomic characterization of squamous cell lung cancers. Nature (2012) 18.90
Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell (2005) 15.06
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell (2012) 11.69
Diverse somatic mutation patterns and pathway alterations in human cancers. Nature (2010) 10.83
Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell (2004) 8.16
Ras oncogenes: split personalities. Nat Rev Mol Cell Biol (2008) 7.91
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet (2009) 7.48
Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell (2011) 7.30
The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell (2009) 6.44
Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell (2012) 6.09
New driver mutations in non-small-cell lung cancer. Lancet Oncol (2011) 6.03
A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell (2010) 6.00
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A (2011) 5.53
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell (2003) 5.17
Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell (2011) 4.78
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet (2012) 4.70
A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell (2009) 4.64
Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell (2012) 4.58
Sox2(+) adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell (2011) 4.29
Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci U S A (2011) 3.82
Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell (2010) 3.70
Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts. J Clin Oncol (2006) 3.53
Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell (2001) 3.43
Epithelial progenitor cells in lung development, maintenance, repair, and disease. Annu Rev Cell Dev Biol (2011) 3.09
Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell (2011) 3.00
The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell (2013) 2.97
Tgfbeta signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Curr Biol (2009) 2.89
Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung. Proc Natl Acad Sci U S A (2010) 2.71
Direct lineage conversions: unnatural but useful? Nat Biotechnol (2011) 2.69
Integrin α6β4 identifies an adult distal lung epithelial population with regenerative potential in mice. J Clin Invest (2011) 2.54
The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev (1999) 2.52
Targeted therapy in non-small-cell lung cancer--is it becoming a reality? Nat Rev Clin Oncol (2010) 2.26
SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One (2010) 2.21
Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types. Clin Cancer Res (2010) 2.15
Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling. Proc Natl Acad Sci U S A (2011) 2.13
SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. Proc Natl Acad Sci U S A (1999) 2.06
Sox2 is important for two crucial processes in lung development: branching morphogenesis and epithelial cell differentiation. Dev Biol (2008) 2.06
Metaplasia and transdifferentiation: from pure biology to the clinic. Nat Rev Mol Cell Biol (2007) 1.95
Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer. Int J Cancer (2010) 1.76
Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma. Proc Natl Acad Sci U S A (2012) 1.73
Tracheal Basal cells: a facultative progenitor cell pool. Am J Pathol (2010) 1.53
Genome-wide mapping of SMAD target genes reveals the role of BMP signaling in embryonic stem cell fate determination. Genome Res (2009) 1.27
Direct reprogramming by oncogenic Ras and Myc. Proc Natl Acad Sci U S A (2013) 1.26
A novel classification of lung cancer into molecular subtypes. PLoS One (2012) 1.13
SnapShot: Lung cancer models. Cell (2012) 1.05
Alveolar type II cells possess the capability of initiating lung tumor development. PLoS One (2012) 0.96
Stem cells and repair of lung injuries. Respir Res (2004) 0.96
Do all lung adenocarcinomas follow a stepwise progression? Lung Cancer (2011) 0.96
Advancing personalized cancer medicine in lung cancer. Arch Pathol Lab Med (2012) 0.76